Higher blood levels of the pollutant hexachlorobenzene (HCB), once widely used as a pesticide and later restricted in many countries…
Articles by Margarida Maia, PhD
Caregivers across Canada can now access free professional mental health support specifically tailored to the unique challenges of caring for…
A pivotal Phase 3 clinical trial testing pridopidine, an experimental oral therapy being developed by Prilenia Therapeutics and…
Brooke Eby, who was diagnosed with amyotrophic lateral sclerosis (ALS) in 2022 at age 33, has been named the …
Tanabe Pharma Canada has announced the publication of a new book featuring personal letters from people living with…
Amydis has received a $2.5 million grant from the National Institutes of Health (NIH) to develop a simple eye…
Scientists have developed a way to deliver a nerve-protecting substance past the brain’s natural defenses using fat-based ‘bubbles,’ a strategy…
Dosing has begun in a new arm of the HEALEY ALS platform trial, with Regimen I — the ninth —…
The experimental therapy QRL-201 successfully reached its biological target and showed early signs that it may slow disease progression in…
Early treatment with PrimeC, an experimental oral treatment being developed by Neurosense Therapeutics, significantly extended survival in people with…